Genentech, Inc. et al v. Granules Pharmaceuticals, Inc. et al
| Genentech, Inc. and InterMune, Inc. |
| Granules India Ltd., Granules USA, Inc. and Granules Pharmaceuticals, Inc. |
| 1:2019cv00164 |
| January 28, 2019 |
| US District Court for the District of Delaware |
| Richard G Andrews |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on March 28, 2019. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Pro Hac Vice Attorneys Chidambaram S. Iyer and Michael R. Dzwonczyk for Granules India Ltd., Granules Pharmaceuticals, Inc., and Granules USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ddp) |
SO ORDERED, re #11 MOTION for Pro Hac Vice Appearance of Attorney Chidambaram S. Iyer and Michael R. Dzwonczyk, filed by Granules India Ltd., Granules Pharmaceuticals, Inc., Granules USA, Inc.. Signed by Judge Richard G. Andrews on 3/26/2019. (nms)
|
| Filing 11 MOTION for Pro Hac Vice Appearance of Attorney Chidambaram S. Iyer and Michael R. Dzwonczyk - filed by Granules India Ltd., Granules Pharmaceuticals, Inc., Granules USA, Inc.. (Ormerod, Eve) |
| Pro Hac Vice Attorneys Ryan Hagglund, Warren K. MacRae, and Mark E. Waddell for Genentech, Inc. and InterMune, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-cv-00078-RGA et al.(ddp) |
|
SO ORDERED, re (11 in 19-cv-78-RGA, 8 in 19-cv-154-RGA, 7 in 19-cv-202-RGA, 8 in 19-cv-130-RGA, 9 in 19-cv-103-RGA, 9 in 19-cv-110-RGA, 9 in 19-cv-123-RGA, 8 in 19-cv-205-RGA, 8 in 19-cv-219-RGA, 10 in 19-cv-178-RGA, 13 in 19-cv-131-RGA, 7 in 19-cv-223-RGA, 7 in 19-cv-142-RGA, 7 in 19-cv-136-RGA, 11 in 19-cv-104-RGA, 8 in 19-cv-190-RGA, 7 in 19-cv-141-RGA, 8 in 19-cv-177-RGA, 13 in 19-cv-132-RGA, 9 in 1:19-cv-00120-RGA, 8 in 19-cv-111-RGA, 8 in 19-cv-195-RGA, 9 in 19-cv-105-RGA, 9 in 1:19-cv-00109-RGA, 7 in 19-cv-203-RGA, 10 in 19-cv-164-RGA) MOTION for Pro Hac Vice Appearance of Attorney Mark E. Waddell, Warren K. MacRae and Ryan Hagglund of LOEB & LOEB LLP filed by Genentech, Inc., InterMune, Inc.. Signed by Judge Richard G. Andrews on 2/12/2019. Associated Cases: 1:19-cv-00078-RGA et al.(nms)
|
| Filing 10 MOTION for Pro Hac Vice Appearance of Attorney Mark E. Waddell, Warren K. MacRae and Ryan Hagglund of LOEB & LOEB LLP - filed by Genentech, Inc., InterMune, Inc.. (Jacobs, Karen) |
| Filing 9 STIPULATION TO EXTEND TIME to move, answer, or otherwisse respond to the Complaint to April 26, 2019 - filed by Genentech, Inc., InterMune, Inc.. (Jacobs, Karen) |
|
SO ORDERED, re #9 STIPULATION TO EXTEND TIME to move, answer, or otherwisse respond to the Complaint to April 26, 2019 (*Reset Answer Deadlines: Granules India Ltd. answer due 4/26/2019; Granules Pharmaceuticals, Inc. answer due 4/26/2019; Granules USA, Inc. answer due 4/26/2019). Signed by Judge Richard G. Andrews on 2/7/2019. (nms)
|
| Filing 8 SUMMONS Returned Executed by InterMune, Inc., Genentech, Inc.. Granules India Ltd. served on 2/5/2019, answer due 2/26/2019. (Jacobs, Karen) |
| Filing 7 DECLARATION of Mailing, by Genentech, Inc., InterMune, Inc.. (Blumenfeld, Jack) Modified on 2/1/2019 (nms). |
| Filing 6 SUMMONS Returned Executed by InterMune, Inc., Genentech, Inc.. Granules USA, Inc. served on 1/29/2019, answer due 2/19/2019. (Blumenfeld, Jack) |
| Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:19-cv-00120-RGA, 1:19-cv-00123-RGA, 1:19-cv-00130-RGA through 1:19-cv-00132-RGA, 1:19-cv-00136-RGA, 1:19-cv-00141-RGA, 1:19-cv-00142-RGA, 1:19-cv-00154-RGA and 1:19-cv-00164-RGA (rjb) |
| Summons Issued with Magistrate Consent Notice attached as to Granules India Ltd. on 1/29/2019; Granules Pharmaceuticals, Inc. on 1/29/2019; Granules USA, Inc. on 1/29/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (nmg) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Genentech, Inc. for InterMune, Inc.; Other Affiliate Roche Holding Ltd., Other Affiliate Novartis Ltd., Other Affiliate Roche Holdings, Inc. for Genentech, Inc. filed by Genentech, Inc., InterMune, Inc.. (nmg) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,383,150 B2; 8,420,674 B2; 8,778,947 B2. (nmg) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 12/20/2018. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 4/15/2022. (nmg) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) |
| Filing 1 COMPLAINT for PATENT INFRINGEMENT filed against Granules India Ltd., Granules Pharmaceuticals, Inc., Granules USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2554841.) - filed by InterMune, Inc., Genentech, Inc.. (Attachments: #1 Exhibit 1-3, #2 Civil Cover Sheet)(nmg) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
